IOL CHEMICALS & PHARM. | ZIM LABORATORIES | IOL CHEMICALS & PHARM./ ZIM LABORATORIES |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.9 | 36.7 | 37.8% | View Chart |
P/BV | x | 1.6 | 3.0 | 52.5% | View Chart |
Dividend Yield | % | 1.0 | 0.0 | - |
IOL CHEMICALS & PHARM. ZIM LABORATORIES |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
ZIM LABORATORIES Mar-23 |
IOL CHEMICALS & PHARM./ ZIM LABORATORIES |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 388 | 138.3% | |
Low | Rs | 272 | 67 | 403.6% | |
Sales per share (Unadj.) | Rs | 377.6 | 81.8 | 461.8% | |
Earnings per share (Unadj.) | Rs | 23.7 | 5.0 | 472.6% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 8.6 | 367.0% | |
Dividends per share (Unadj.) | Rs | 4.00 | 0 | - | |
Avg Dividend yield | % | 1.0 | 0 | - | |
Book value per share (Unadj.) | Rs | 256.8 | 41.1 | 624.6% | |
Shares outstanding (eoy) | m | 58.71 | 48.73 | 120.5% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 2.8 | 38.5% | |
Avg P/E ratio | x | 17.1 | 45.4 | 37.6% | |
P/CF ratio (eoy) | x | 12.8 | 26.5 | 48.4% | |
Price / Book Value ratio | x | 1.6 | 5.5 | 28.4% | |
Dividend payout | % | 16.9 | 0 | - | |
Avg Mkt Cap | Rs m | 23,743 | 11,096 | 214.0% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 493 | 341.1% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 3,985 | 556.3% | |
Other income | Rs m | 256 | 64 | 399.3% | |
Total revenues | Rs m | 22,427 | 4,049 | 553.8% | |
Gross profit | Rs m | 2,257 | 520 | 434.1% | |
Depreciation | Rs m | 462 | 175 | 264.2% | |
Interest | Rs m | 165 | 56 | 295.4% | |
Profit before tax | Rs m | 1,887 | 354 | 533.6% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 109 | 453.3% | |
Profit after tax | Rs m | 1,391 | 244 | 569.4% | |
Gross profit margin | % | 10.2 | 13.0 | 78.0% | |
Effective tax rate | % | 26.2 | 30.9 | 85.0% | |
Net profit margin | % | 6.3 | 6.1 | 102.4% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 1,909 | 506.2% | |
Current liabilities | Rs m | 5,025 | 1,108 | 453.6% | |
Net working cap to sales | % | 20.9 | 20.1 | 104.1% | |
Current ratio | x | 1.9 | 1.7 | 111.6% | |
Inventory Days | Days | 43 | 19 | 222.1% | |
Debtors Days | Days | 8 | 872 | 1.0% | |
Net fixed assets | Rs m | 11,017 | 1,569 | 702.1% | |
Share capital | Rs m | 587 | 487 | 120.5% | |
"Free" reserves | Rs m | 14,490 | 1,516 | 955.7% | |
Net worth | Rs m | 15,077 | 2,003 | 752.6% | |
Long term debt | Rs m | 0 | 246 | 0.0% | |
Total assets | Rs m | 20,684 | 3,479 | 594.6% | |
Interest coverage | x | 12.5 | 7.3 | 169.6% | |
Debt to equity ratio | x | 0 | 0.1 | 0.0% | |
Sales to assets ratio | x | 1.1 | 1.1 | 93.6% | |
Return on assets | % | 7.5 | 8.6 | 87.2% | |
Return on equity | % | 9.2 | 12.2 | 75.7% | |
Return on capital | % | 13.6 | 18.2 | 74.8% | |
Exports to sales | % | 26.7 | 81.1 | 33.0% | |
Imports to sales | % | 0 | 12.2 | 0.0% | |
Exports (fob) | Rs m | 5,930 | 3,230 | 183.6% | |
Imports (cif) | Rs m | NA | 485 | 0.0% | |
Fx inflow | Rs m | 5,930 | 3,281 | 180.7% | |
Fx outflow | Rs m | 6,052 | 485 | 1,247.0% | |
Net fx | Rs m | -122 | 2,796 | -4.4% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 375 | 325.9% | |
From Investments | Rs m | -1,200 | -362 | 331.5% | |
From Financial Activity | Rs m | -41 | 5 | -752.7% | |
Net Cashflow | Rs m | -18 | 30 | -61.3% |
Indian Promoters | % | 48.2 | 33.3 | 144.9% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 0.0 | 17,000.0% | |
FIIs | % | 1.4 | 0.0 | 14,000.0% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 66.7 | 77.6% | |
Shareholders | 130,003 | 17,100 | 760.3% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES SUN PHARMA CIPLA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | ZIM LABORATORIES | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 2.53% | 11.26% | 1.12% |
1-Month | 7.41% | 27.76% | 1.19% |
1-Year | 2.27% | 58.45% | 53.88% |
3-Year CAGR | -12.43% | 7.63% | 14.71% |
5-Year CAGR | 16.58% | -0.53% | 19.28% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the ZIM LABORATORIES share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of ZIM LABORATORIES the stake stands at 33.3%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of ZIM LABORATORIES.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
ZIM LABORATORIES paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of ZIM LABORATORIES.
For a sector overview, read our pharmaceuticals sector report.
Japan's Nikkei 225 led gains in Asia as markets in the region rose across the board, following Wall Street's continued rally for a second straight day.